Delivery Order SPE2DB24D9144-SPE2DB24FCMLB

Award Date 9/9/24
Potential Completion Date 9/30/24
Potential Value $10K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $10,093.50 contract is for the supply of Nuplazid 34 mg capsules with a performance period through May 28, 2024. This delivery order is placed under DMS Pharmaceutical Group's $499,999,999 single-award Indefinite Delivery Contract (IDC) with the DLA, which allows the agency to issue firm...
This federal contract award was made by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $3,364.50 firm fixed-price delivery order contract is for the supply of the prescription medication Nuplazid 34 mg capsules. The award is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program, which covers a...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract valued at $10,093.50 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, which has an ultimate completion date of December 9, 2024, is for the delivery of Nuplazid 34 mg capsules. DMS Pharmaceutical Group holds a larger Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999 and...
The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $10,093.50 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of 4,566,210,999 units of the pharmaceutical product Nuplazid 34 mg capsule 30s. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $499,999,999 that DMS Pharmaceutical Group holds with the DLA under the SPE2DB program. The IDC covers a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $10,375.53 firm fixed-price contract is for the delivery of Nuplazid 34 mg capsules, with a completion date of July 7, 2025. DMS Pharmaceutical Group holds a larger $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows the agency to issue delivery orders for a comprehensive...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $10,093.50 firm fixed-price delivery order is for the supply of NUPLAZID 34 MG CAPSULE 30S, a pharmaceutical product. The award is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999 that DMS Pharmaceutical Group holds with the DLA under the SPE2DB program. This IDC allows the DLA to issue...
The U.S. Defense Logistics Agency (DLA) awarded a $10,214.82 firm-fixed price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide the medication Nuplazid 10 mg tablet. This order was placed under DMS Pharmaceutical Group's existing indefinite delivery contract (IDC) with the DLA, valued at up to $499,999,999, which supports the recurring pharmaceutical supply needs of the Department of Defense's (DoD) military health facilities worldwide. DMS...
The U.S. Defense Logistics Agency awarded a firm fixed-price delivery order contract, valued at $10,093.50, to DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business located in Park Ridge, Illinois. The contract is for the delivery of NUPLAZID 34 MG CAPSULE 30S to support the medical supply needs of the agency. This delivery order falls under DMS Pharmaceutical Group's larger indefinite delivery contract, SPE2DB, with the Defense Logistics Agency, which has a potential value...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $6,729 contract is for the delivery of Nuplazid 34 mg capsules by January 3, 2025. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the agency to issue firm fixed-price delivery orders for a wide range...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $3,458.51 firm fixed-price delivery order is for the provision of NUPLAZID 34 MG CAPSULE 30S, a specialized pharmaceutical product, with a performance period through April 8, 2025. DMS Pharmaceutical Group holds a significant $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the...
  • SPE2DB24D9144
    Indefinite Delivery Contract
  • SPE2DB24D9144-SPE2DB24FCMLB
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $10,093.50 fixed-price delivery order is for the supply of Nuplazid 34 mg capsules, and is part of a larger $499,999,999 indefinite delivery contract (IDC) that DMS Pharmaceutical Group holds with the DLA under the SPE2DB program. This IDC allows the DLA to issue firm fixed-price delivery orders to DMS for a comprehensive range of pharmaceutical items to fulfill the recurring medical supply needs of military health facilities worldwide. The contract does not have a set-aside designation. Through this and other prime vendor contracts, DMS Pharmaceutical Group provides both routine and critical medications, including specialized drugs and medical supplies, to support the diverse medical requirements of Department of Defense (DoD) healthcare facilities and their personnel.

Generated 12/9/24, 1:47 PM